Effect of Angiotensin II Receptor Blocker on Plasma Levels of TGF-β1 and Interstitial Fibrosis in Hypertensive Kidney Transplant Patients

Publisher： Karger

E-ISSN： 1421-9670|23|5|300-306

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.23, Iss.5, 2003-09, pp. : 300-306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Valsartan, an Angiotensin II AT1 Receptor Blocker, on the Glomerular Fibrosis of IgA Nephropathy in ddY Mice

By  

Nephron, Vol. 86, Iss. 3, 2000-11 ,pp. : 374-375

Karger

Access to resources Recommend Favorite

Impact of Angiotensin II Receptor Blocker on Plasma Levels of Adiponectin and Advanced Oxidation Protein Products in Peritoneal Dialysis Patients

By  

Blood Purification, Vol. 24, Iss. 5-6, 2006-12 ,pp. : 445-450

Karger

Access to resources Recommend Favorite

Usual ACE Inhibitor Therapy in CKD Patients Is Associated with Lower Plasma Aldosterone Levels than Usual Angiotensin Receptor Blocker Therapy

By  

Kidney and Blood Pressure Research, Vol. 30, Iss. 5, 2007-07 ,pp. : 299-305

Karger

Access to resources Recommend Favorite

The Role of Apelin on the Alleviative Effect of Angiotensin Receptor Blocker in Unilateral Ureteral Obstruction-Induced Renal Fibrosis

By  

Nephron Extra, Vol. 2, Iss. 1, 2012-03 ,pp. : 39-47

Karger

Access to resources Recommend Favorite

No Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin 2 Receptor Blocker Intake with Acute Kidney Injury in Patients Undergoing Kidney Biopsy

By  

Kidney and Blood Pressure Research, Vol. 35, Iss. 6, 2012-08 ,pp. : 558-560

Karger

Access to resources Recommend Favorite